MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0056357
Glyco Bio Pharma Private Limited
Glyco Bio Pharma Private Limited - events and entertainment in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.9 Cr
▼ 22% YoY
Net profit · FY 2024
₹3.04 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹10.76 Lakh
EBITDA margin 5.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹36 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Glyco Bio Pharma Private Limited
Data last updated:
Glyco Bio Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the event planning and management segment of the events and entertainment sector. It was incorporated on 28 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC117995. Its GSTIN is 36AAGCG8980L1ZV (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sekhar Babu Mandava and Sujitha Sekharababu Mandava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5 – 9 – 234/1 Part – I New Rajiv Gandhi Nagar Idpl, Hyderabad, Telangana, India – 500004.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.9 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹3.04 Lakh (net margin 1.6%) and EBITDA of ₹10.76 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 27% over five years.
The company is associated with 1 brand: Glyco Biopharma. As per MCA filings, the company has open charges of ₹36 Lakh on record.
Glyco Bio Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0056357). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999TG2017PTC117995
Registration Number 117995
Incorporation Date 28 June 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0056357
Recognitions & Rankings of Glyco Bio Pharma
Contact details
Glyco Bio Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address5 – 9 – 234/1 Part – I New Rajiv Gandhi Nagar Idpl, Hyderabad, Telangana, India – 500004
- IndustryEvents and Entertainment, Event Planning & Management
To see the full contact details of Glyco Bio Pharma Private Limited, buy the company report.
Comprehensive company report
Glyco Bio Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Glyco Bio Pharma operates one associated brand: Glyco Biopharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides comprehensive solutions in feed supplements and antibiotics for poultry, aquaculture, and veterinary sectors. | glycobiopharma.com |
Business activity
The main business activity of Glyco Bio Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Glyco Bio Pharma Private Limited, buy the company report.
Financials of Glyco Bio Pharma Private Limited
FY 2025 filings availableGlyco Bio Pharma Private Limited reported revenue of ₹1.9 Cr (down 22% YoY) for FY 2024.
Revenue · FY 2024
₹1.9 Cr ▼ 22%
Net profit · FY 2024
₹3.04 Lakh margin 1.6%
EBITDA · FY 2024
₹10.76 Lakh margin 5.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 9%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▼ 24%
3 years · compounded
▲ 38%
5 years · compounded
▲ 66%
Revenue fell 22% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 27%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glyco Bio Pharma Private Limited, buy the company report.
Board of directors of Glyco Bio Pharma Private Limited
Glyco Bio Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sekhar Babu Mandava Also directs: Genetheraptics Pharma Private Limited | Director | 28 Jun 2017 | 9 Years 4 Months | Current |
| Sujitha Sekharababu Mandava Also directs: Genetheraptics Pharma Private Limited | Director | 28 Jun 2017 | 9 Years 4 Months | Current |
Auditor
Glyco Bio Pharma Private Limited is audited by DASARI RAMESH & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DASARI RAMESH & ASSOCIATES | FY 2018 | 014294S |
Shareholding
The shareholding of Glyco Bio Pharma Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Glyco Bio Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹36 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Mar 2022 | 100555890 | Axis Bank Limited | ₹36 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Glyco Bio Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glyco Bio Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Glyco Bio Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCG8980L1ZV | Telangana | Active | 01 Mar 2018 |
| 37AAGCG8980L1ZT | Andhra Pradesh | Active | 04 Mar 2020 |
To see the full GST registrations and return filing status of Glyco Bio Pharma Private Limited, buy the company report.
Recent activity
Glyco Bio Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Sekhar Babu Mandava was appointed as Director on 28 Jun 2017.
AGM
Glyco Bio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Glyco Bio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 36.00 Lakh with Charge ID 100555890 was registered on 22 Mar 2022.
Appointed
Sekhar Babu Mandava was appointed as Director.
Appointed
Sujitha Sekharababu Mandava was appointed as Director.
Incorporation
28 Jun 2017
Glyco Bio Pharma Private Limited was registered on 28 Jun 2017 with Roc Hyderabad & aged 9 years 4 months as per MCA records.
Frequently asked questions
Glyco Bio Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in event planning and management, within the events and entertainment industry. It was incorporated on 28 June 2017 (9+ years old) and is registered under CIN U74999TG2017PTC117995.
Glyco Bio Pharma has 2 current directors:
- Sekhar Babu Mandava - Director
- Sujitha Sekharababu Mandava - Director
The latest financial statements of Glyco Bio Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Glyco Bio Pharma is 36AAGCG8980L1ZV, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAGCG8980L1ZT (Andhra Pradesh).
The CIN (Corporate Identification Number) of Glyco Bio Pharma is U74999TG2017PTC117995. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glyco Bio Pharma was incorporated on 28 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sekhar Babu Mandava was appointed as Director on 28 Jun 2017. Sujitha Sekharababu Mandava was appointed as Director on 28 Jun 2017.
Yes, Glyco Bio Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0056357).
The registered office of Glyco Bio Pharma is at 5 – 9 – 2341 Part – I New Rajiv Gandhi Nagar Idpl, Hyderabad, Telangana, India – 500004.
Glyco Bio Pharma operates in the events and entertainment industry, in the event planning and management segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages